Congenital adrenal hyperplasia refers to a group of genetic disorders that affect the adrenal glands. These glands sit on top of the kidneys and release hormones the body needs to function. CAH creates imbalances in these hormones, which cause a wide range of symptoms in infants, children, and adults.
Treatment of all forms of CAH may include supplying enough glucocorticoid to reduce hyperplasia and overproduction of androgens or mineralocorticoids
We identified 104 adult patients (101 alive) with classical CAH (63% female), yielding overall incidence at 1/20 000 live births (1/16 000 in females). Seventy-two (72%) responded; median age 38 years (range 18?72). All the SF-36 scales were significantly impaired, most pronounced for general health and vitality perception. Working disability was reported by 19% of the patients, compared with 10% in the general population. The female patients were often single, and the CAH women had only 21% of the expected number of children compared with the general population.
Current research studies aims to improve our understanding of poor growth in children who have normal growth-hormone secretion, improve the final adult height of children with congenital adrenal hyperplasia (CAH)